A Novel Mutation in Aicardi–Goutières' Syndrome: A Case Report

Abstract

Aicardi–Goutières' syndrome (AGS) is a rare heterogeneous genetic disorder characterized by encephalopathy and may bear resemblance to congenital infections. The prevalence of AGS is estimated at more than 4,000 worldwide. Mutations in TREX1 gene are present in ∼22% of patients. We present the case of a 2-year-old boy who came to the Biogene laboratory (Tehran, Iran) with a constellation of congenital disorders but no clear diagnosis. His clinical phenotype consisted of neonatal jaundice, relative microcephaly with diffuse cerebral atrophy in both hemispheres, developmental delay, hypotonia, and nystagmus. There was history of parental consanguineous marriage and prematurity. In our study, a homozygous potentially pathogenic mutation in TREX1 gene associated with AGS1 was detected. This mutation has not been reported in the other patients with AGS. A novel frameshift homozygous potentially pathogenic mutation in TREX1 is postulated to be the cause of disease in our patient.

Keywords

Aicardi–Goutières' syndrome - TREX1 gene - novel mutation

Publication History

Received: 06 January 2020

Accepted: 17 August 2020

Article published online:
21 September 2020

• References

• 1 Aicardi J, Goutières F. A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Ann Neurol 1984; 15 (01) 49-54
• 2 Moscote-Salazar LR, Calderon-Miranda WG, Deluquez Baute RV. et al. Aicardi–Goutières syndrome: brief case report. J Pediatr Neurosci 2018; 13 (01) 88-90
• 3 Haaxma CA, Crow YJ, van Steensel MA. et al. A de novo p.Asp18Asn mutation in TREX1 in a patient with Aicardi-Goutières syndrome. Am J Med Genet A 2010; 152A (10) 2612-2617
• 4 Rice GI, Forte GM, Szynkiewicz M. et al. Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. Lancet Neurol 2013; 12 (12) 1159-1169
• 5 Fazzi E, Cattalini M, Orcesi S. et al. Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder?. Autoimmun Rev 2013; 12 (04) 506-509
• 6 Guadagni MG, Faggella A, Piana G, D'Alessandro G. Aicardi syndrome: a case report. Eur J Paediatr Dent 2010; 11 (03) 146-148
• 7 Crow YJ, Shetty J, Livingston JH. Treatments in Aicardi-Goutières syndrome. Dev Med Child Neurol 2020; 62 (01) 42-47
• 8 Livingston JH, Crow YJ. Neurologic phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi–Goutieres syndrome and beyond. Neuropediatrics 2016; 47 (06) 355-360
• 9 Arjmand B, Larijani B, Sheikh Hosseini M. et al. The horizon of gene therapy in modern medicine: advances and challenges. Adv Exp Med Biol 2020; 1247: 33-64
• 10 Al Mutairi F, Alfadhel M, Nashabat M. et al. Phenotypic and molecular spectrum of Aicardi-Goutières syndrome: a study of 24 patients. Pediatr Neurol 2018; 78: 35-40
• 11 Kisla Ekinci RM, Balci S, Bisgin A, Altintas DU, Yilmaz M. A homozygote TREX1 mutation in two siblings with different phenotypes: chilblains and cerebral vasculitis. Eur J Med Genet 2017; 60 (12) 690-694
• 12 Lee-Kirsch MA, Chowdhury D, Harvey S. et al. A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. J Mol Med (Berl) 2007; 85 (05) 531-537
• 13 Rice G, Newman WG, Dean J. et al. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. Am J Hum Genet 2007; 80 (04) 811-815
• 14 Crow YJ, Hayward BE, Parmar R. et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus. Nat Genet 2006; 38 (08) 917-920
• 15 Morita M, Stamp G, Robins P. et al. Gene-targeted mice lacking the Trex1 (DNase III) 3′–>5′ DNA exonuclease develop inflammatory myocarditis. Mol Cell Biol 2004; 24 (15) 6719-6727
• 16 Sakai T, Miyazaki T, Shin DM. et al. DNase-active TREX1 frame-shift mutants induce serologic autoimmunity in mice. J Autoimmun 2017; 81: 13-23
• 17 Crow YJ, Black DN, Ali M. et al. Cree encephalitis is allelic with Aicardi-Goutiéres syndrome: implications for the pathogenesis of disorders of interferon alpha metabolism. J Med Genet 2003; 40 (03) 183-187
• 18 Huang KW, Liu TC, Liang RY. et al. Structural basis for overhang excision and terminal unwinding of DNA duplexes by TREX1. PLoS Biol 2018; 16 (05) e2005653
• 19 Crow YJ, Rehwinkel J. Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Hum Mol Genet 2009; 18 (R2): R130-R136
• 20 Rice G, Patrick T, Parmar R. et al. Clinical and molecular phenotype of Aicardi-Goutieres syndrome. Am J Hum Genet 2007; 81 (04) 713-725
• 21 Rice GI, Kasher PR, Forte GM. et al. Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Nat Genet 2012; 44 (11) 1243-1248
• 22 La Piana R, Uggetti C, Roncarolo F. et al. Neuroradiologic patterns and novel imaging findings in Aicardi-Goutières syndrome. Neurology 2016; 86 (01) 28-35